German Pharmaceuticals & Biotech Potentially Undervalued Companies

Sandoz Group

Market Cap: €14.1b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

Perrigo

Market Cap: €3.4b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Charles River Laboratories International

Market Cap: €4.9b

Charles River Laboratories International, Inc.

ACADIA Pharmaceuticals

Market Cap: €2.4b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Trulieve Cannabis

Market Cap: €890.1m

Operates as a cannabis retailer.

Novo Nordisk

Market Cap: €1.9t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Shionogi

Market Cap: €1.9t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

Protara Therapeutics

Market Cap: €143.8m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Tilray Brands

Market Cap: €485.9m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

Merck KGaA

Market Cap: €51.1b

Operates as a science and technology company in Germany.

Gossamer Bio

Market Cap: €187.5m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.

TerrAscend

Market Cap: €133.3m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Mirum Pharmaceuticals

Market Cap: €1.9b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Navamedic

Market Cap: €338.2m

A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.

Aytu BioPharma

Market Cap: €8.4m

A pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally.

Clinuvel Pharmaceuticals

Market Cap: €536.4m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Novo Nordisk

Market Cap: €1.9t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Cellectis

Market Cap: €102.2m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates.

Emergent BioSolutions

Market Cap: €238.5m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.

Genmab

Market Cap: €80.8b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Newbury Pharmaceuticals

Market Cap: €80.1m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

Genmab

Market Cap: €80.8b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Biogen

Market Cap: €16.9b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Adaptimmune Therapeutics

Market Cap: €57.2m

A commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom.

Shanghai Haohai Biological Technology

Market Cap: €12.2b

Shanghai Haohai Biological Technology Co., Ltd.

Almirall

Market Cap: €2.0b

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

Gerresheimer

Market Cap: €1.8b

Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.

CSPC Pharmaceutical Group

Market Cap: €66.2b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, North America, Europe, and internationally.

Bavarian Nordic

Market Cap: €11.7b

Develops, manufactures, and supplies life-saving vaccines.

Pfizer

Market Cap: €124.3b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Pharming Group

Market Cap: €491.1m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

Pharming Group

Market Cap: €491.1m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

Planet 13 Holdings

Market Cap: €110.6m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

H. Lundbeck

Market Cap: €27.6b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Newron Pharmaceuticals

Market Cap: €129.5m

A biopharmaceutical company, focus on the discovery and development of novel therapies for the treatment of central nervous system (CNS) and pain in Italy and the United States.

Delivra Health Brands

Market Cap: €5.3m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.